Most Popular Stories
- FDA maps out long-awaited rules for the biosimilars business
- FDA approvals of 2011
- Mouse study triggers demands for a possible Alzheimer's treatment
- High price of failure drives drug development costs into the stratosphere
- Eisai loses panel vote on new Dacogen use
- GSK, Takeda say nay to in-house diagnostics units
Webinars
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
Featured Jobs
-
Associate Manager, Global Supply Chain Planning (1 of 3) Job
Celgene Corporation - Basking Ridge, NJ, US -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Clinical Research Associate
Jennerex, Inc - San Francisco, CA -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US
Events
- Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Pharmaceutical Strategic Outlook
April 11-13, 2012 - DCAT Week 2012
Mar 12-15 — New York City - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Biosimilars: A Physician Perspective
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- Pharma 2.0: Heading Toward Social Media Marketing
- Biologically Active Molecules: Chemical Research, Development and Scale-up
- Online Multilingual marketing strategy
- Forum Signature File : solution for Media Marketing
Janet Woodcock
